Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| CDC-NCCDPHP-MM-0444 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of North Carolina | OTHER |
The primary goal of this study is to assess the effectiveness and feasibility of the Active Living Every Day Physical Activity Program (ALED) for people with arthritis. This project is designed to evaluate the effectiveness of the ALED program in changing arthritis-related health outcomes and to investigate the feasibility of conducting the ALED program in a public health setting.
Evidence has shown that regular moderate-intensity physical activity improves symptoms and function in persons with arthritis. A 20-week behavior-based program was developed by the Cooper Institute, Brown University, and Human Kinetics to help people with sedentary lifestyles become and stay physically active. A randomized trial evaluated the effectiveness and efficacy of a similar program on which Active Living Every Day is based (ALED) on cardiovascular disease risk factors, cost-effectiveness, and cardiorespiratory fitness. However, the current research supporting ALED is limited for people with arthritis. The primary goal of this study is to assess the effectiveness and feasibility of the Active Living Every Day Physical Activity Program (ALED) for people with arthritis. The primary goal will be accomplished through a twenty week randomized controlled trial conducted with 400 participants residing in the 17 Area Agencies on Aging housed in the Councils of Government in North Carolina, including both urban and rural counties. This project is designed to evaluate the effectiveness of the ALED program in changing arthritis-related health outcomes and to investigate the feasibility of conducting the ALED program in a public health setting.
Objectives:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Active Living Every Day | Behavioral |
| Measure | Description | Time Frame |
|---|---|---|
| Physical Activity Level measured via CHAMPS instrument at baseline and 20 weeks | ||
| Physical Fitness Level measued via 2 minute step test at baseline and 20 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Functional status measured via HAQ at baseline and 20 weeks | ||
| Arthritis Self-efficacy measured at baseline and 20 weeks | ||
| Health-related Quality of Life measured at baseline, 20 weeks, 6 months and 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jennifer M Hootman, PhD | Centers for Disease Control and Prevention | Study Chair |
| Leigh F Callahan, PhD | University of North Carolina, Chapel Hill | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D010003 | Osteoarthritis |
| D001172 | Arthritis, Rheumatoid |
| D012216 | Rheumatic Diseases |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Pain, fatigue and stiffness VAS at baseline and 20 weeks |
| Activities of Daily Living measured at baseline, 20 weeks, 6 months and 12 months |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D001519 | Behavior |